What is the Neurizon Therapeutics (ASX: NUZ) share price?
The NUZ share price is $0.061, down 1.61% for the day, based on the latest available ASX market data.
What is Neurizon Therapeutics's market capitalisation?
Neurizon Therapeutics has a market capitalisation of $46.0M, making it the 1045th-largest security listed on the ASX.
Does Neurizon Therapeutics pay a dividend?
NUZ does not currently have a dividend on record. Some companies, particularly those reinvesting in growth or not yet profitable, do not pay dividends.
Is Neurizon Therapeutics profitable?
In its most recent reported period (ending 30 June 2025), NUZ reported revenue of $0 and a net loss of $16.6M.
How many NUZ shares are on issue?
Neurizon Therapeutics has approximately 753,983,000 shares on issue, based on its market capitalisation of $46.0M and current share price.
What sector is Neurizon Therapeutics in?
Neurizon Therapeutics is classified in the Healthcare sector, within the Biotechnology industry on the ASX.
When did Neurizon Therapeutics list on the ASX?
Neurizon Therapeutics listed on the Australian Securities Exchange on 6 Oct 2024.
